These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 22119394)

  • 1. Cerebroprotective effects of TAK-937, a cannabinoid receptor agonist, on ischemic brain damage in middle cerebral artery occluded rats and non-human primates.
    Suzuki N; Suzuki M; Murakami K; Hamajo K; Tsukamoto T; Shimojo M
    Brain Res; 2012 Jan; 1430():93-100. PubMed ID: 22119394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: therapeutic time window, combination with t-PA and efficacy in aged rats.
    Murakami K; Suzuki M; Suzuki N; Hamajo K; Tsukamoto T; Shimojo M
    Brain Res; 2013 Aug; 1526():84-93. PubMed ID: 23791950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of hypothermia and CB1 receptor activation to protective effects of TAK-937, a cannabinoid receptor agonist, in rat transient MCAO model.
    Suzuki N; Suzuki M; Hamajo K; Murakami K; Tsukamoto T; Shimojo M
    PLoS One; 2012; 7(7):e40889. PubMed ID: 22815855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effect of osthole against acute ischemic stroke on middle cerebral ischemia occlusion in rats.
    Chao X; Zhou J; Chen T; Liu W; Dong W; Qu Y; Jiang X; Ji X; Zhen H; Fei Z
    Brain Res; 2010 Dec; 1363():206-11. PubMed ID: 20869955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose dependence and therapeutic window for the neuroprotective effects of curcumin in thromboembolic model of rat.
    Dohare P; Garg P; Jain V; Nath C; Ray M
    Behav Brain Res; 2008 Nov; 193(2):289-97. PubMed ID: 18611416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the balance between cannabinoid CB(1) and CB(2) receptor activation during cerebral ischemic/reperfusion injury.
    Zhang M; Martin BR; Adler MW; Razdan RK; Ganea D; Tuma RF
    Neuroscience; 2008 Mar; 152(3):753-60. PubMed ID: 18304750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of combination of endothelin receptor antagonist (TAK-044) and aspirin in middle cerebral artery occlusion model of acute ischemic stroke in rats.
    Briyal S; Gulati A; Gupta YK
    Methods Find Exp Clin Pharmacol; 2007 May; 29(4):257-63. PubMed ID: 17609737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotection of early and short-time applying atorvastatin in the acute phase of cerebral ischemia: down-regulated 12/15-LOX, p38MAPK and cPLA2 expression, ameliorated BBB permeability.
    Cui L; Zhang X; Yang R; Wang L; Liu L; Li M; Du W
    Brain Res; 2010 Apr; 1325():164-73. PubMed ID: 20167207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of treatment with low-dose gliclazide in a model of middle cerebral artery occlusion and reperfusion in rats.
    Tan F; Li H; Ma M; Yu Y
    Brain Res; 2014 Apr; 1560():83-90. PubMed ID: 24602692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of endothelin antagonist (TAK-044) on cerebral ischemic volume, oxidative stress markers and neurobehavioral parameters in the middle cerebral artery occlusion model of stroke in rats.
    Gupta YK; Briyal S; Sharma U; Jagannathan NR; Gulati A
    Life Sci; 2005 May; 77(1):15-27. PubMed ID: 15848215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracarotid injection of granulocyte-macrophage colony-stimulating factor induces neuroprotection in a rat transient middle cerebral artery occlusion model.
    Nakagawa T; Suga S; Kawase T; Toda M
    Brain Res; 2006 May; 1089(1):179-85. PubMed ID: 16678804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin protects against middle cerebral artery occlusion induced focal cerebral ischemia in rats.
    Chauhan A; Sharma U; Jagannathan NR; Reeta KH; Gupta YK
    Behav Brain Res; 2011 Dec; 225(2):603-9. PubMed ID: 21903138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment with melatonin exerts anti-inflammatory effects against ischemia/reperfusion injury in a rat middle cerebral artery occlusion stroke model.
    Pei Z; Cheung RT
    J Pineal Res; 2004 Sep; 37(2):85-91. PubMed ID: 15298666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effect of L-serine against temporary cerebral ischemia in rats.
    Wang GH; Jiang ZL; Chen ZQ; Li X; Peng LL
    J Neurosci Res; 2010 Jul; 88(9):2035-45. PubMed ID: 20186763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat.
    Allahtavakoli M; Moloudi R; Arababadi MK; Shamsizadeh A; Javanmardi K
    Brain Res; 2009 May; 1271():121-7. PubMed ID: 19332033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MP-124, a novel poly(ADP-ribose) polymerase-1 (PARP-1) inhibitor, ameliorates ischemic brain damage in a non-human primate model.
    Matsuura S; Egi Y; Yuki S; Horikawa T; Satoh H; Akira T
    Brain Res; 2011 Sep; 1410():122-31. PubMed ID: 21741620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effect of nitroglycerin in a rodent model of ischemic stroke: evaluation of Bcl-2 expression.
    Greco R; Amantea D; Blandini F; Nappi G; Bagetta G; Corasaniti MT; Tassorelli C
    Int Rev Neurobiol; 2007; 82():423-35. PubMed ID: 17678976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous cannabinoids contribute to remote ischemic preconditioning via cannabinoid CB2 receptors in the rat heart.
    Hajrasouliha AR; Tavakoli S; Ghasemi M; Jabehdar-Maralani P; Sadeghipour H; Ebrahimi F; Dehpour AR
    Eur J Pharmacol; 2008 Jan; 579(1-3):246-52. PubMed ID: 17950273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated administration of exendin-4 reduces focal cerebral ischemia-induced infarction in rats.
    Briyal S; Gulati K; Gulati A
    Brain Res; 2012 Jan; 1427():23-34. PubMed ID: 22055454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.